Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management

Inclusion Criteria: * Informed consent obtained after being advised of the nature of the study * Male or female aged 18 - 90 years (both inclusive) * Type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four Exclusion Criteria: * Impaired renal function (serum creatinine ≥3.0mg/dL) * Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient * Pregnancy * Any mental condition rendering the patient incapable of giving his consent * Terminally ill patients * Participation in a trial within 3 months prior to this trial * Known or suspected allergy to insulin